Goserelin (Zoladex)

FDA-approved product existsPeptideGH axis & hormones

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Goserelin (Zoladex)?

FDA-approved goserelin is marketed as Zoladex implants for product-specific uses in prostate cancer, breast cancer, endometriosis, and endometrial thinning.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelZOLADEX 3.6 mg prescribing information for its approved oncology and gynecologic indications
PopulationAdults covered by the approved ZOLADEX indications
DoseOne 3.6 mg implant
RouteSubcutaneous implant in the upper abdominal wall by a healthcare professional
FrequencyEvery 28 days
DurationIndication-specific; the label specifies 6 months for endometriosis
PreparationReady-to-use 3.6 mg implant supplied in a single-dose prefilled syringe; no reconstitution.
Source: Dosage and Administration sections 2.1-2.7; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.